PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
01-Jun-2020 Lynparza recommended for approval in EU by CHMP for BRCA-mutated metastatic pancreatic cancer AstraZeneca PLC
01-Jun-2020 Immutep announces improving data from the phase II TACTI-002 study Immutep
01-Jun-2020 Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75 Calliditas Therapeutics
29-May-2020 Santhera Provides Update on the Ongoing Regulatory Review of Puldysa® (Idebenone) by the CHMP in Duchenne Muscular Dystrophy (DMD) Santhera Pharmaceuticals
29-May-2020 Interim analysis presented at the American Society of Clinical Oncology (ASCO) Annual Meeting London’s Global University
29-May-2020 First patient dosed in Achilles’ Phase I/II study in melanoma Syncona
28-May-2020 Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration Sanofi
28-May-2020 COVID-19: RSC offers grants for scientists working from home Royal Society of Chemistry
28-May-2020 Gavi: Partnering to protect future generations from infectious diseases ABPI
28-May-2020 Roche’s Tecentriq gains first-line approval in NSCLC but Keytruda reigns supreme, says GlobalData Roche
28-May-2020 Vectura provides AGM trading update and reiterates 2020 guidance Vectura
28-May-2020 Sareum to Present at BIO Digital 2020 Sareum
28-May-2020 Oxitec’s New Friendly Aedes aegypti Mosquito Technology Receives Full Biosafety Approval in Brazil Oxitec
28-May-2020 Laboratory relocation specialist backs NHS tribute Aport
28-May-2020 Pivotal Preclinical Oncology Platform Expands to Include New Patient-Derived Organoid Models Hubrecht Organoid Technology
28-May-2020 Oxitec’s New Friendly Aedes aegypti Mosquito Technology Receives Full Biosafety Approval in Brazil Oxitec Ltd
28-May-2020 Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation Cidara Therapeutics, Inc
28-May-2020 IRBM’s Advent announces manufacture of 13,000 doses of Covid-19 vaccine, for use in Phase 2/3 clinical trials by the University of Oxford IRBM Group
28-May-2020 Almac Group Supports Two COVID-19 Clinical Studies in Sub-Saharan Africa Almac Group
22-May-2020 Cherwell prepared media accessories help reduce risk in EM Cherwell Laboratories